Clinical Trials Browser

Phase 3 × uproleselan × 1 year × Clear all

NCT05054543 2025-06-27

Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML

Phase 3 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute